• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

TPLC - Total Product Life Cycle

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

New Search show TPLC since Back to Search Results
Device surgical cardiac ablation device, for treatment of atrial fibrillation
Definition Surgical cardiac ablation for the treatment of atrial fibrillation.
Product CodeOCM
Device Class 3

Premarket Approvals (PMA)
2021 2022 2023 2024 2025 2026
1 5 7 2 5 0

MDR Year MDR Reports MDR Events
2021 6 6
2022 5 5
2023 3 3
2024 16 16
2025 10 10
2026 3 3

Device Problems MDRs with this Device Problem Events in those MDRs
Adverse Event Without Identified Device or Use Problem 35 35
Activation, Positioning or Separation Problem 1 1
Output Problem 1 1
Suction Failure 1 1
Positioning Problem 1 1
Therapeutic or Diagnostic Output Failure 1 1
Labelling, Instructions for Use or Training Problem 1 1
Explosion 1 1
Suction Problem 1 1

Patient Problems MDRs with this Patient Problem Events in those MDRs
Cardiac Perforation 8 8
Stroke/CVA 5 5
No Clinical Signs, Symptoms or Conditions 5 5
Pericardial Effusion 3 3
Pulmonary Valve Stenosis 3 3
Cardiac Tamponade 2 2
Insufficient Information 2 2
Great Vessel Perforation 2 2
Hemorrhage/Bleeding 2 2
Ischemia Stroke 2 2
Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available 1 1
Arrhythmia 1 1
Perforation 1 1
Pericarditis 1 1
Cardiac Arrest 1 1
Ventricular Fibrillation 1 1
Hernia 1 1
Paresis 1 1
Heart Failure/Congestive Heart Failure 1 1
Stenosis 1 1
Fistula 1 1

-
-